Clopidogrel-Induced Interstitial Lung Disease: A Case Report
Jin An,1 Seung Hwan Lee,2 Boksoon Chang1 1Department of Pulmonary, Allergy and Critical Care Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Republic of Korea; 2Department of Neurosurgery, Stroke and Neurological Disorder Center, Kyung Hee Unive...
Guardado en:
Autores principales: | An J, Lee SH, Chang B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6eb35231aa8a4cd8bf3441b0c4644cc8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
por: Kreutz RP, et al.
Publicado: (2016) -
Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar S, et al.
Publicado: (2020) -
Drug-Induced Interstitial Lung Disease after Anthracycline-Combined Chemotherapy for Breast Cancer: A Case Report and Literature Review
por: Hideko Hoshina, et al.
Publicado: (2021) -
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala FS, et al.
Publicado: (2020) -
Assessing the Safety and Efficacy of Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease
por: Mohamed Mustafa Elsheikh, et al.
Publicado: (2021)